Orally administered GLP-1 analogs can access the liver at much higher concentrations via the hepatic portal vein than via subcutaneous delivery, reducing systemic exposure
In 2024, Wegovy was also approved to reduce the risk of heart attack, stroke, or cardiovascular death in obese or overweight adults with cardiovascular disease
Appropriate appetite suppression and steady weight loss (1-1.5 pounds per week) are the most common indicators we use to evaluate your response
You are not hungry, but you know you should eat You fill up in a few bites and then feel stuck Heavy textures and strong smells are harder to handle Your protein has quietly dropped lower than you would like Some days nothing sounds good at all This plan gives you a week of meals that are small enough to finish, soft enough to feel good, and protein-rich enough to support your body without asking too much of your appetite
it is a complex interplay of hormones, genetics, and environment
Sometimes the highest number means a drug isnt covered